Buy article

Patient-reported chronic rhinosinusitis disease control is a valid measure of disease burden

Volume: 0 - Issue: 0

First page: 0 - Last page: 0

K.M. Phillips - F.A. Houssein - K. Singerman - L.M. Boeckermann - A.R. Sedaghat

Background: Disease control is an important treatment goal for chronic uncurable conditions such as chronic rhinosinusitis (CRS). The objective of this study was to determine whether patient-reported CRS disease control is a valid reflection of disease burden.
Methods: Prospective longitudinal study of 300 CRS patients (35% CRS with nasal polyps, 65% CRS without nasal polyps). At enrollment and at a subsequent follow-up timepoint, all participants were asked to rate their CRS disease control as “not at all,” “a little,” “somewhat,” “very,” or “completely”, as well as to complete a 22-item Sinonasal Outcome Test (SNOT-22) and the 5-dimension EuroQol general health questionnaire from which the visual analogue scale (EQ-5D VAS) was used.
Results: At enrollment and follow-up timepoints, patient-reported CRS disease control was significantly correlated with SNOT-22 and EQ-5D VAS scores. The change in patient-reported CRS disease control was significantly correlated with change in SNOT-22 and change in EQ-5D VAS scores. There was significant cross-sectional and longitudinal correlation between patient-reported control and all SNOT-22 subdomain scores. A SNOT-22 score of ≤ 25 points or lower, or an EQ-5D VAS score of ≥77 was predictive of having well - (i.e. “very” or “completely”) controlled CRS.
Conclusions: Patient-reported CRS disease control is a valid measure of CRS disease burden and general QOL. A patient-reported assessment of CRS disease control could be considered as a component of a more comprehensive measure of CRS disease control.

Rhinology 0-0: 0-0, 0000

To see the issue content and the abstract you do not have to login

Please login to download the full articles

If you do not have a subscription to Rhinology please consider taking one.

Click here to become a member of the European Rhinologic Society and a subscriber to the journal `RHINOLOGY`, from 2022. Subscription including membership fee: Euro 135.-

  1. Slot Online
  2. Situs Slot Online Terbaik Dan Terpercaya No 1
  3. Slot Gacor
  4. Daftar Situs Judi Slot Online
  5. Slot Terbaru:
  6. Slot Pragmatic Play
  7. Situs Slot Online Terpercaya
  8. Kumpulan Situs Judi Slot Terpercaya
  9. Game Slot Online
  10. Judi Slot Online Jackpot Terbesar
  11. Situs Judi Slot Online Terpercaya 2021
  12. Situs Slot Online Indonesia
  13. SLOT88
  14. 777 Slot Online
  15. Slot Joker123
  16. Situs Slot Online Terbaik
  17. Daftar Situs Slot Online
  18. Agen Slot Online Resmi
  19. Slot Deposit Pulsa
  20. Situs Slot Gacor
  21. Situs Judi Slot Online Terbaik & Judi Online 2021
  22. Agen Slot Online Terpercaya
  23. Daftar Situs Judi Slot Terbaik Dan Terpercaya No 1
  24. Link Alternatif Joker123
  25. Pragmatic Play Indonesia
  26. Daftar Situs Judi Slot Online Gampang Menang Terbaik 2021
  27. Raja Bet
  28. AloJudi Slot
  29. KayaMendadak88 Slot
  30. Situs Judi Slot Online:
  31. Situs slot gacor online terpercaya:
  32. Situs Judi Slot Online Joker Slot Gaming
  33. Judi Slot Online SLOT88
  34. Slot Online Gacor
  35. Judi Slot Pragmatic Play
  36. Link Alternatif: